Research Grant Awarded to Advance Alpha Therapy Imaging

The Theragnostic Imaging group has received funding for a three-year full time research position + running costs from the Southern and Eastern Norway Regional Health Authority for ImALPHA! The research project is aiming to advance post-treatment imaging of targeted alpha therapy.

Alpha therapy imaging with current technology suffers from low count rates and high scatter. Building on our previous pilot studies and early-phase clinical trials, the project will develop new imaging technologies specifically adapted to these challenges. The research will include the development of optimized reconstruction built with refined simulation models for camera response, validation through prospective studies with parallel clinical trials, and in silico models to prepare future clinical trials.

Caroline Stokke is PI and group member Monika Kvassheim will be closely involved.